Xynomic Pharmaceuticals (XYNO) Short Interest Ratio & Short Volume

$2.22

0.00 (0.00%)

(As of 06/23/2021)

Stock Analysis

Xynomic Pharmaceuticals Short Interest Data

Short Selling Xynomic Pharmaceuticals ?

Sign up to receive the latest short interest report for Xynomic Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
6/15/2021	600 shares	$1,332.00	No Change	N/A	0	$2.22
5/28/2021	600 shares	$1,332.00	No Change	N/A	6	$2.22
5/14/2021	600 shares	$1,332.00	No Change	N/A	6	$2.22
4/30/2021	600 shares	$1,296.00	No Change	N/A	6	$2.16
4/15/2021	600 shares	$1,248.00	No Change	N/A	0	$2.08
3/31/2021	600 shares	$1,248.00	No Change	N/A	3	$2.08
3/15/2021	600 shares	$1,398.00	-14.3%	N/A	6	$2.33
2/26/2021	700 shares	$1,631.00	-53.3%	N/A	1.8	$2.33
2/12/2021	1,500 shares	$4,275.00	No Change	N/A	1.9	$2.85
1/29/2021	1,500 shares	$2,550.00	No Change	N/A	2.5	$1.70
1/15/2021	2,500 shares	$6,025.00	No Change	N/A	25	$2.41
12/31/2020	1,600 shares	$6,144.00	-36.0%	N/A	0.9	$3.84
12/15/2020	2,500 shares	$6,500.00	No Change	N/A	25	$2.60
11/30/2020	2,500 shares	$6,500.00	No Change	N/A	25	$2.60
10/30/2020	2,500 shares	$5,750.00	+66.7%	N/A	0.1	$2.30
10/15/2020	1,500 shares	$0.00	-34.8%	N/A	7.5	$0.00

What is Xynomic Pharmaceuticals' current short interest?: Short interest is the volume of Xynomic Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 600 shares of XYNO short. Learn More on Xynomic Pharmaceuticals' current short interest.
How does Xynomic Pharmaceuticals' short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Xynomic Pharmaceuticals: Context Therapeutics Inc. (0.29%), Grifols, S.A. (2.57%), IMV Inc. (1.31%), LAVA Therapeutics (1.37%), and Mainz Biomed (2.30%).
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: AstraZeneca PLC ($7.95 billion), Tesla, Inc. ($7.86 billion), Block, Inc. ($7.16 billion), Aon plc ($7.04 billion), Advanced Micro Devices, Inc. ($6.99 billion), Analog Devices, Inc. ($6.83 billion), S&P Global Inc. ($6.30 billion), Charter Communications, Inc. ($5.98 billion), AMC Entertainment Holdings, Inc. ($5.02 billion), and Wayfair Inc. ($4.68 billion). View all of the most shorted stocks.

What does it mean to sell short Xynomic Pharmaceuticals stock?: Short selling XYNO is an investing strategy that aims to generate trading profit from Xynomic Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Xynomic Pharmaceuticals?: A short squeeze for Xynomic Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XYNO, which in turn drives the price of the stock up even further.
How often is Xynomic Pharmaceuticals' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XYNO, twice per month. The most recent reporting period available is June, 15 2021.

Related Companies:

Short Interest Tools:

This page (OTCMKTS:XYNO) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners